Lipofilling for Healing of Chronic Wounds
Primary Purpose
Wound Healing Disorder
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Lipofilling (sublesional fat grafting)
Sponsored by

About this trial
This is an interventional treatment trial for Wound Healing Disorder
Eligibility Criteria
Inclusion Criteria:
- Patients with leg ulcers of any origin (venous, arterial, mixed arterial-venous, diabetogenic, compressive)
- Age of ulcer > 6 weeks
- Ulcer size >= 1 cm (minimum diameter)
- Ulcer / wound with complete destruction of the epidermis (including basement membrane)
- Patient age > 18 years
- Patient Consent
Exclusion Criteria:
- Pregnancy
- Exposed tendons, ligaments, or bone if maximum diameter > 2 mm
- Ulcer size > 10 cm
- Immediately preceding vacuum bandage therapy (< 2 weeks)
- Possibilities for correcting the cause of the ulcer
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention group
Control group
Arm Description
The intervention group received a fat grafting under the wound bed and into the wound edges.
The control group received an injection of saline solution (0.9%) under the wound bed and into the wound edges.
Outcomes
Primary Outcome Measures
Reduction of wound area
The reduction of the wound area from intervention to 14 days and 2 month post-intervention
Secondary Outcome Measures
Pain wound
Subjective pain level of the patient in the area of the wound, measured by the visual analogue scale pre and post intervention
Bacterial contamination wound
Wound swabs were taken pre intervention and on days 7, 14 and 21 after intervention
Full Information
NCT ID
NCT05509673
First Posted
August 18, 2022
Last Updated
August 18, 2022
Sponsor
University of Witten/Herdecke
Collaborators
Cologne-Merheim Medical Center (CMMC)
1. Study Identification
Unique Protocol Identification Number
NCT05509673
Brief Title
Lipofilling for Healing of Chronic Wounds
Official Title
Clinical Trial to Improve Wound Healing of Chronic Lower Leg Ulcers by Autologous Transplantation of Fat Tissue
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
June 29, 2011 (Actual)
Primary Completion Date
November 30, 2016 (Actual)
Study Completion Date
March 6, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Witten/Herdecke
Collaborators
Cologne-Merheim Medical Center (CMMC)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Chronic wounds remain a therapeutic and financial challenge for physicians and the health care systems. Innovative, cheap and effective treatment methods would be of immense value. The sublesional fat grafting could be such treatment, although the effectiveness and safety have not been assessed in large randomized clinical trials. The aim of this trial was to analyse the effect of adipose tissue on the healing of chronic lower leg wounds. For this purpose, the wounds were surgically cleaned (wound debridement) and then fat was suctioned out from the stomach or thighs and then injected into the edges of the wound and under the wounds. The wounds are covered with a foam dressing that is changed every 3-4 days. There are controls on days 3, 7, 14 and 21 after the intervention and a follow-up examination 2 months after the intervention. The primary objective is the reduction of the wound area 14 days and 2 month after intervention. Secondary objectives are pain level of the wound, bacterial colonialisation of the wound and analysis of the grafted fat tissue (ammount of mesenchymal stem cells)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Healing Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Masking Description
Digital analysis of wound area is masked
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
The intervention group received a fat grafting under the wound bed and into the wound edges.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The control group received an injection of saline solution (0.9%) under the wound bed and into the wound edges.
Intervention Type
Other
Intervention Name(s)
Lipofilling (sublesional fat grafting)
Primary Outcome Measure Information:
Title
Reduction of wound area
Description
The reduction of the wound area from intervention to 14 days and 2 month post-intervention
Time Frame
14 days and 2 month
Secondary Outcome Measure Information:
Title
Pain wound
Description
Subjective pain level of the patient in the area of the wound, measured by the visual analogue scale pre and post intervention
Time Frame
2 month
Title
Bacterial contamination wound
Description
Wound swabs were taken pre intervention and on days 7, 14 and 21 after intervention
Time Frame
3 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with leg ulcers of any origin (venous, arterial, mixed arterial-venous, diabetogenic, compressive)
Age of ulcer > 6 weeks
Ulcer size >= 1 cm (minimum diameter)
Ulcer / wound with complete destruction of the epidermis (including basement membrane)
Patient age > 18 years
Patient Consent
Exclusion Criteria:
Pregnancy
Exposed tendons, ligaments, or bone if maximum diameter > 2 mm
Ulcer size > 10 cm
Immediately preceding vacuum bandage therapy (< 2 weeks)
Possibilities for correcting the cause of the ulcer
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oliver C Thamm, MD, PhD
Organizational Affiliation
University of Witten/Herdecke
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Lipofilling for Healing of Chronic Wounds
We'll reach out to this number within 24 hrs